Although we also observed a substantial number of CEBPA -mutant patients ( n = 10), this association did not reach statistical significance.
← all excerpts
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
1
—
—
Although we also observed a substantial number of CEBPA -mutant patients ( n = 10), this association did not reach statistical significance.